Current Radiopharmaceuticals (CRP)

Current Radiopharmaceuticals is a specialist scientific journal devoted to advancing research and clinical practice in the field of radiopharmaceutical science. First published in 2008, the journal has built a reputation for disseminating rigorous, peer-reviewed research on the design, development, and evaluation of radioactively labelled compounds used in diagnostic imaging and targeted radionuclide therapy. Published by Bentham Science Publishers, it appears regularly in quarterly issues, presenting high-impact findings from both basic and applied domains of radiopharmaceutical research. The journal’s scope spans cutting-edge studies on novel radionuclides, molecular imaging probes, and advanced tracer technologies, as well as comprehensive review articles that synthesize trends and challenges in nuclear medicine. Articles include evaluations of tracer biodistribution, dosimetry assessments, clinical trial reports on new radiotherapeutics, and methodological advances in imaging modalities like PET and SPECT. The interdisciplinary nature of Current Radiopharmaceuticals makes it a valuable resource for scientists, radiochemists, clinicians, and healthcare professionals focused on improving diagnostic accuracy and therapeutic outcomes. Its readership includes experts in radiology, oncology, pharmaceutical sciences, and biomedical engineering, reflecting the journal’s role in shaping the future of radiopharmaceutical innovation.

Current Radiopharmaceuticals (CRP) is :-

• International, Peer-Reviewed, Open Access, Refereed, Radiolabelled compound development, including synthesis, Molecular imaging and diagnostic radiopharmaceuticals, emphasizing radio-tracers for PET, SPECT, and hybrid modalities like PET/CT and SPECT/CT, Applications in oncology (tumor imaging and therapy), neurology, cardiology, Preclinical and clinical studies detailing pharmacokinetics, dosimetry, safety, efficacy of radiolabelled drugs , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1874-4710, E-ISSN: 1874-4729, Established: 2009, Impact Factor: 1.2
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE